Join us for an in-depth discussion with experts in precision medicine. This panel discussion will center on the current state and future direction of precision medicine. Topics we will cover include:
- Update on NIH’s All of Us research program, which aims to gather biological, environmental, and lifestyle health data from at least 1 million U.S. individuals to promote medical breakthroughs
- The importance of developing reference databases that encompass a wide array of backgrounds
- The role of AI and machine learning
- FDA’s recent initiatives to advance Next Generation Sequencing (NGS) testing
- The role of pharmacogenetics
- FDA’s regulation of DTC testing kits, such as 23andme
Speakers
Michael Blum, Executive Director, Center for Digital Health Innovation, University of California, San Francisco
Karen Corallo, Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP
Joseph Fireman, Product Counsel, Verily Life Sciences
Katja Schulze, US Medical Affairs Biomarket Leader, Genentech
Moderated by Kai Peters, Partner, Gordon & Rees LLP
View Our Other California Programs
Sponsorship Opportunities
Sponsorship opportunities are available. Please let us know if you would like more information.
Agenda
subject to change
Wednesday, June 5
4:30 PM – 4:45 PM
FDLI Welcome
4:45 PM – 6:00 PM
Moderated panel discussion with Q&A
6:00 PM – 7:00 PM
Reception
Location and Overnight Accommodations
Panel Location
Genentech
651 Gateway Blvd, South San Francisco, CA 94080
Overnight Accommodations
Courtyard by Marriott
Airport/Oyster Point Waterfront
1300 Veterans Boulevard, South San Francisco, CA 94080
Driving, Parking, and Public Transportation
Please contact the Conference Department with any accessibility requirements or dietary restrictions, or for other questions.